Showing results (471-480 of 8,076) with videos related to

Sort By:
Pageof 808
Clinical and Experimental Rheumatology|October 19, 2021
Parotid salivary sodium levels of Sjögren's syndrome patients suggest B-cell mediated epithelial sodium channel disruptionSarah A Pringle, Bas Berkhof, Marthe van Ginkel, et al.
Clinical and Experimental Rheumatology|October 19, 2021
Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activityBrendan Antiochos, Merlin Paz, Jessica Li, et al.
Clinical and Experimental Rheumatology|August 30, 2018
One year in review 2018: Sjögren's syndromeOurania D Argyropoulou, Eleonora Valentini, Francesco Ferro, et al.
Clinical and Experimental Rheumatology|August 30, 2018
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project)Pilar Brito-Zerón, Nihan Acar-Denizli, Wan-Fai Ng, et al.
Clinical and Experimental Rheumatology|August 30, 2018
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndromeAlessia Alunno, Elena Bartoloni, Valentina Valentini, et al.
Clinical and Experimental Rheumatology|August 30, 2018
Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)Alejandra Flores-Chávez, Belchin Kostov, Roser Solans, et al.
Clinical and Experimental Rheumatology|October 10, 2018
Successful use of rituximab in granulomatosis with polyangiitis with aortic inflammationLucas Pineda Bernal, Nicole Bitencourt, Kiran Batra, et al.
Clinical and Experimental Rheumatology|October 10, 2018
Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factorsElizabeth Blair Solow, Wanpen Vongpatanasin, Brian Skaug, et al.
Clinical and Experimental Rheumatology|October 10, 2018
Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT studyJosé Luis Pablos, Federico Navarro, Francisco José Blanco, et al.
Clinical and Experimental Rheumatology|October 10, 2018
Prevalence of sicca syndrome in the Peruvian populationLuz Arelis Moreno-Quispe, Ibis Veronica Nieves Velarde-Grados, Magna Guzmán-Avalos, et al.
Pageof 808